EditorialFree What We Believe June 05, 2020Vol.46 No.23By Alexandria Carolan, Katie Goldberg, Matthew Bin Han Ong and Paul Goldberg
FreeGuest Editorial I could have been George Floyd—many timesReflecting on the cancer of racism June 05, 2020Vol.46 No.23By Robert A. Winn
Drugs & TargetsFree Opdivo + Yervoy receive FDA approval combined with limited chemotherapy as first-line treatment of metastatic or recurrent NSCLC May 29, 2020Vol.46 No.22
Drugs & TargetsFree Brigatinib receives FDA approval for ALK-positive metastatic NSCLC May 29, 2020Vol.46 No.22
Drugs & TargetsFree CLR 131 receives fast track designation in lymphoplasmacytic lymphoma/Waldenstrom’s macroglobulinemia May 29, 2020Vol.46 No.22
Clinical RoundupFree Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma May 29, 2020Vol.46 No.22
Clinical RoundupFree Fox Chase researchers investigate perceived barriers to discussing sexual issues in breast cancer patients May 29, 2020Vol.46 No.22
Clinical RoundupFree Evidence from two studies demonstrates efficacy of Immunoscore May 29, 2020Vol.46 No.22
